Cases 41 - 50 of 58
Pfizer Inc. et al v. Alembic Pharmaceuticals, Inc. et al.
as 1:2019cv00745
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Alembic Pharmaceuticals, Inc. and Alembic Pharmacauticals, Ltd.
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals, Inc. v. Puretek Corporation
as 2:2019cv02817
Defendant:
Puretek Corporation
Plaintiff:
Alembic Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 44
Genentech, Inc. et al v. Alembic Pharmaceuticals, Ltd., et al
as 1:2019cv00177
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Alembic Pharmaceuticals, Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2018cv01762
Defendant:
Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals Limited et al v. GlaxoSmithKline LLC et al
as 1:2018cv01513
Plaintiff:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Defendant:
Glaxo Group Limited and GlaxoSmithKline LLC
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Alembic Pharmaceuticals Limited, et al
as 1:2018cv00113
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding S/A and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Adverio Pharma GmbH et al v. Alembic Pharmaceuticals Limited et al
as 1:2018cv00073
Plaintiff:
Adverio Pharma GmbH , Bayer AG and Bayer HealthCare Pharmaceuticals Inc.
Defendant:
Alembic Pharmaceuticals Limited , Alembic Global Holding S/A , Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271
DUKE UNIVERSITY et al v. ALEMBIC PHARMACEUTICALS, LTD et al
as 3:2017cv07453
Plaintiff:
DUKE UNIVERSITY , ALLERGAN, INC. and ALLERGAN SALES, LLC
Defendant:
ALEMBIC PHARMACEUTICALS, LTD, ALEMBIC GLOBAL HOLDING SA and ALEMBIC PHARMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al
as 1:2017cv00675
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
